The holy grail: Immune control of human herpes simplex virus infection and disease

Herpes

Volumn 8, Issue SUPPL. 1, 2001, Pages

  Cunningham, A L ^a   Mikloska, Z ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

CD4 and CD8 lymphocytes; Epidermal cells; Genital herpes; Herpes simplex virus; Interferon ; Vaccines

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; VACCINE;

DENDRITIC CELL; EFFECTOR CELL; GENITAL HERPES; HELPER CELL; HERPES; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION CONTROL; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; VACCINATION; VIRUS REPLICATION;

CLINICAL TRIALS; HERPES GENITALIS; HERPES SIMPLEX VIRUS VACCINES; HUMANS; RECURRENCE;

ANIMALIA; HERPES; SIMPLEXVIRUS;

EID: 0035066848     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Global epidemiology of sexually transmitted diseases
2. Prospects for control of herpes simplex virus disease through immunization
3. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons
4. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2
5. Genital herpes
6. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions
7. Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro
8. Evolution of recurrent herpes simplex virus lesions
9. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with IFN-γ
10. Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8 cytotoxic T lymphocytes
11. Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP
12. Herpes simplex virus turns off TAP to evade host immunity
13. + T-cells produce gamma-interferon in patients with recurrent herpes labialis
14. Significance of local γ interferon in recurrent herpes simplex infection
15. The role of keratinocytes in human recurrent herpetic lesions: Ability to present HSV antigen and act as targets for T-lymphocyte cytotoxicity in vitro
16. MPL and QS21 increase CD8 T Lymphocyte Cytotoxicity to HSV-2 ICP4 and ICP27 through IFN-γ and IL-12 production
17. In vivo production of cytokines and β (C-C) chemokines in human recurrent herpes simplex virus lesions - Do herpes simplex virus infected keratinocytes contribute to their production?
18. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
19. IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro
20. Cytokine-mediated control of viral infections
21. Interferon-γ enhances resolution of herpes simplex virus type 2 infection of the murine genital tract
22. γ-interferon production appears to predict time of recurrence of herpes labialis
23. High frequency of CD8 cytotoxic T lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes
24. Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions
25. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes
26. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes
27. Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognise immediate early protein ICP27
28. Antigenic specificities of human CD4 T cell clones recovered from recurrent genital herpes simplex virus type 2 lesions
29. Viral persistence in neurons explained by lack of major histocompatibility class I expression
30. Granzyme A, a non-cytolytic component of CD8+ cell granules, restricts the spread of herpes simplex virus in the peripheral nervous systems of experimentally infected mice
31. CD8+ T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons
32. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection. Two randomized controlled trials
33. A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2
34. Synergistic association of adjuvants QS21 and MPL for induction of cytolytic T-lymphocytes and T-helper responses to recombinant protein antigens
35. Gender-specific efficacy of a prophylatic SBAS4-adjuvant gD, subunit vaccine against genital herpes disease (GHD): Results of two clinical efficacy trials
36. The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1
37. Immunisation with human immunodeficiency virus type I rgp120W61D in QS21/MPL adjuvant primes T cell proliferation and C-C chemokine production to multiple epitopes within variable and conserved domains of gp120W61D
38. DNA immunization confers protective immunity in mice challenged intravaginally with herpes simplex virus type 2
39. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination
40. DNA vaccines for viral infections: Basic studies and applications
41. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity